EP3882249
Tvívetnis-setnar afleiður af rúxólítíníb
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.6.2013EP published:
14.5.2025EP application number:
21156398.6
EP translation filed:
22.8.2025Grant published:
15.9.2025EPO information:
European Patent Register
Max expiry date:
13.6.2033Expiry date:
13.6.2026Next due date:
30.6.2026
Title in English:
DEUTERATED DERIVATIVES OF RUXOLITINIBLanguage of the patent:
English
Timeline
Today
14.6.2013EP application
14.5.2025EP Publication
22.8.2025Translation submitted
15.9.2025Registration published
13.6.2026Expires
Owner
Name:
Sun Pharmaceutical Industries, Inc.Address:
2 Independence Way, Princeton, NJ 08540, US
Inventor
Name:
Silverman, I. RobertAddress:
Arlington, Massachusetts 02474, US
Name:
Liu, Julie F.Address:
Lexington, Massachusetts 02420, US
Name:
Morgan, Adam J.Address:
Ashland, Massachusetts 01721, US
Name:
Pandya, BhaumikAddress:
Bedford, Massachusetts 01730, US
Name:
Harbeson, Scott L.Address:
Ellenton, Florida 34222-2025, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261660428 PDate:
15.6.2012Country:
US
Number:
201261678795 PDate:
2.8.2012Country:
US
Classification
Categories:
C07D 487/04, C07B 59/00, A61K 31/519, A61P 35/02
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 23.6.2025
Expires: 13.6.2026
Payer: Árnason Faktor ehf.